Monday, April 12, 2021

CATEGORIES

Medication

LATEST

TRENDING

EDITORS CHOICE

Psilocybin as an Antidepressant for Cancer Patients Who Are Not Depressed

Research concerning the role of psychedelics in mental health treatment and its superb publicity campaign depends on millions of dollars raised by venture capitalists.

Blaming the Psychiatric Patient When It’s a Drug-Genetic Interaction

How can patients with psychiatric or any other illnesses be viewed as non-compliant with their medical regimes when there is a persistent failure to investigate how their race and genetics are affecting treatment

First Drug Synthesized by AI Goes into Clinical Trials

If all goes well, thanks to artificial intelligence, we may soon have a new AI-synthesized drug capable of assisting OCD patients in managing their symptoms and thus leading normal lives.

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.